Page last updated: 2024-08-24

tenofovir and Bacterial Vaginitides

tenofovir has been researched along with Bacterial Vaginitides in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (80.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Abdool Karim, Q; Abdool Karim, SS; Archary, D; Elsherbini, JA; Kwon, DS; Lewis, L; Mansoor, LE; Mazibuko-Motau, N; Mtshali, A; Mzobe, G; Ngcapu, S; Ntuli, L; San, JE; Sobia, P; Xu, J	1
Baeten, JM; Balkus, JE; Bukusi, E; Celum, C; Cohen, CR; Donnell, D; Fiedler, T; Fredricks, DN; Heffron, R; Kiarie, J; Lingappa, J; McClelland, RS; Mugo, N; Munch, M	1
Abbai, NS; Naidoo, S; Nyirenda, M; Ramjee, G	1
Abdool Karim, SS; Baxter, C; Passmore, JS	1
Deng, L; Dong, A; Li, N; Yang, J; Yu, M	1

Reviews

1 review(s) available for tenofovir and Bacterial Vaginitides

Article	Year
The microbiome and HIV prevention strategies in women. Current opinion in HIV and AIDS, 2018, Volume: 13, Issue:1 Topics: Anti-Retroviral Agents; Female; Gardnerella vaginalis; HIV Infections; Humans; Microbiota; Pre-Exposure Prophylaxis; Pyrimidines; Tenofovir; Treatment Failure; Vagina; Vaginosis, Bacterial	2018

Trials

2 trial(s) available for tenofovir and Bacterial Vaginitides

Article	Year
Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study. The lancet. HIV, 2017, Volume: 4, Issue:10 Topics: Adult; Anti-HIV Agents; Dysbiosis; Emtricitabine; Female; Gardnerella vaginalis; HIV Infections; HIV Seropositivity; HIV-1; Humans; Kenya; Microbiota; Pre-Exposure Prophylaxis; Prospective Studies; Sexual Partners; Tenofovir; Uganda; Vagina; Vaginosis, Bacterial	2017
Prevalent Herpes Simplex Virus-2 Increases the Risk of Incident Bacterial Vaginosis in Women from South Africa. AIDS and behavior, 2018, Volume: 22, Issue:7 Topics: Administration, Intravaginal; Administration, Oral; Adult; Cross-Sectional Studies; Developing Countries; Double-Blind Method; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; Gels; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV Seronegativity; Humans; Incidence; Risk Factors; South Africa; Tenofovir; Unsafe Sex; Vaginosis, Bacterial; Young Adult	2018

Article

Year

Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study.

The lancet. HIV, 2017, Volume: 4, Issue:10

Topics: Adult; Anti-HIV Agents; Dysbiosis; Emtricitabine; Female; Gardnerella vaginalis; HIV Infections; HIV Seropositivity; HIV-1; Humans; Kenya; Microbiota; Pre-Exposure Prophylaxis; Prospective Studies; Sexual Partners; Tenofovir; Uganda; Vagina; Vaginosis, Bacterial

2017

Prevalent Herpes Simplex Virus-2 Increases the Risk of Incident Bacterial Vaginosis in Women from South Africa.

AIDS and behavior, 2018, Volume: 22, Issue:7

Topics: Administration, Intravaginal; Administration, Oral; Adult; Cross-Sectional Studies; Developing Countries; Double-Blind Method; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; Gels; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV Seronegativity; Humans; Incidence; Risk Factors; South Africa; Tenofovir; Unsafe Sex; Vaginosis, Bacterial; Young Adult

2018

Other Studies

2 other study(ies) available for tenofovir and Bacterial Vaginitides

Article	Year
Vaginal microbial shifts are unaffected by oral pre-exposure prophylaxis in South African women. Scientific reports, 2022, 09-28, Volume: 12, Issue:1 Topics: Anti-Bacterial Agents; Cross-Sectional Studies; Emtricitabine; Female; HIV Infections; Humans; Pre-Exposure Prophylaxis; South Africa; Tenofovir; Vagina; Vaginosis, Bacterial	2022
Thermosensitive hydrogel of hydrophobically-modified methylcellulose for intravaginal drug delivery. Journal of materials science. Materials in medicine, 2012, Volume: 23, Issue:8 Topics: Adenine; Administration, Intravaginal; Animals; Anti-HIV Agents; Cells, Cultured; Delayed-Action Preparations; Diffusion; Female; Hot Temperature; Hydrogels; Hydrophobic and Hydrophilic Interactions; Materials Testing; Methylcellulose; Organophosphonates; Rabbits; Tenofovir; Vaginosis, Bacterial	2012

Article

Year

Vaginal microbial shifts are unaffected by oral pre-exposure prophylaxis in South African women.

Scientific reports, 2022, 09-28, Volume: 12, Issue:1

Topics: Anti-Bacterial Agents; Cross-Sectional Studies; Emtricitabine; Female; HIV Infections; Humans; Pre-Exposure Prophylaxis; South Africa; Tenofovir; Vagina; Vaginosis, Bacterial

2022

Thermosensitive hydrogel of hydrophobically-modified methylcellulose for intravaginal drug delivery.

Journal of materials science. Materials in medicine, 2012, Volume: 23, Issue:8

Topics: Adenine; Administration, Intravaginal; Animals; Anti-HIV Agents; Cells, Cultured; Delayed-Action Preparations; Diffusion; Female; Hot Temperature; Hydrogels; Hydrophobic and Hydrophilic Interactions; Materials Testing; Methylcellulose; Organophosphonates; Rabbits; Tenofovir; Vaginosis, Bacterial

2012